perfosfamide has been researched along with mafosfamide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Górski, A; Rychlik, G; Wasik, M | 1 |
| Blomgren, H; Hallström, M | 1 |
| Kohn, FR; Landkamer, GJ; Manthey, CL; Ramsay, NK; Sladek, NE | 1 |
| Linch, DC; Singer, CR | 1 |
| Hoon, DB; Jung, T; McBride, WH; Morton, DL; Naungayan, J; Nizze, A | 1 |
| Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Rowley, SD | 1 |
| Calabretta, B; Malaguarnera, L; Nieborowska-Skórska, M; Ratajczak, MZ; Skórski, T; Szczylik, C | 1 |
| Sladek, NE; Sreerama, L | 1 |
| Murgo, AJ; Weinberger, BB | 1 |
| Morrow, CS; Smitherman, PK; Townsend, AJ | 1 |
| Barnett, MJ; Brockington, DA; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
| Farquhar, D; Wang, YQ | 1 |
1 review(s) available for perfosfamide and mafosfamide
| Article | Year |
|---|---|
Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives.
Topics: Animals; Antineoplastic Agents; Bone Marrow Purging; Clinical Trials as Topic; Cyclophosphamide; Humans; Molecular Structure; Tumor Cells, Cultured | 1993 |
1 trial(s) available for perfosfamide and mafosfamide
| Article | Year |
|---|---|
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Treatment Outcome; Vincristine | 2000 |
11 other study(ies) available for perfosfamide and mafosfamide
| Article | Year |
|---|---|
The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro.
Topics: Aged; Animals; Antibody-Dependent Cell Cytotoxicity; Cyclophosphamide; Cytotoxicity, Immunologic; Humans; Killer Cells, Natural; Mechlorethamine | 1990 |
Possible role of acrolein in oxazaphosphorine-induced enhancement of immunological reactivity.
Topics: Acrolein; Aldehydes; Antineoplastic Agents; Concanavalin A; Cyclophosphamide; Humans; Immunity, Cellular; Lymphocytes; Mitogens; Mitosis; T-Lymphocytes; T-Lymphocytes, Regulatory | 1990 |
Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
Topics: Aldehyde Dehydrogenase; Animals; Colony-Forming Units Assay; Cyanamide; Cyclophosphamide; Disulfiram; Ditiocarb; Drug Resistance; Enzyme Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia L1210; Mice; NAD; Organophosphorus Compounds; Phosphinic Acids; Phosphoramide Mustards | 1987 |
Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Survival; Clone Cells; Cyclophosphamide; Cytarabine; Etoposide; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Melphalan; Transplantation, Autologous; Tumor Cells, Cultured | 1987 |
Cyclophosphamide-induced alterations in human monocyte functions.
Topics: Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Immunity, Cellular; Interleukin-1; Leukocytes, Mononuclear; Melanoma; Tumor Necrosis Factor-alpha; Vaccination | 1987 |
Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1995 |
Bone marrow purging, 4-hydroperoxycyclophosphamide, and the FDA.
Topics: Acute Disease; Bone Marrow; Bone Marrow Purging; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Industry; Drug Utilization; Ethics, Medical; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Neoplasm, Residual; Treatment Outcome; United States; United States Food and Drug Administration | 1993 |
Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
Topics: Antineoplastic Agents; Blast Crisis; Bone Marrow; Bone Marrow Purging; Colony-Forming Units Assay; Cyclophosphamide; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Chronic-Phase; Oligonucleotide Probes; Polymerase Chain Reaction; Tumor Cells, Cultured | 1993 |
Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Benzaldehydes; Breast Neoplasms; Cell Line; Cyclophosphamide; Drug Resistance; Gastric Mucosa; Gene Expression Regulation, Enzymologic; Humans; Hydrogen-Ion Concentration; Isoenzymes; NAD; NADP; Subcellular Fractions; Temperature | 1993 |
Combined expression of multidrug resistance protein (MRP) and glutathione S-transferase P1-1 (GSTP1-1) in MCF7 cells and high level resistance to the cytotoxicities of ethacrynic acid but not oxazaphosphorines or cisplatin.
Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Cyclophosphamide; Cytoprotection; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ethacrynic Acid; Glutathione Transferase; Humans; Membrane Proteins; Transfection; Tumor Cells, Cultured | 1998 |
Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies.
Topics: Animals; Antineoplastic Agents; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Survival; Drug Screening Assays, Antitumor; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Phosphoramide Mustards; Prodrugs; Structure-Activity Relationship | 1991 |